Pioneering molecular engineering technologies for systemic renewal

Harnessing the power of the body’s intercellular communication processes to trigger cellular repair and renewal

Precision therapeutics derived from engineered exosomes

Exosomes are nanoscale extracellular vesicles secreted by all cells to facilitate intercellular communication, naturally transporting proteins, lipids, and genetic material, to modulate gene expression and cellular behavior.

Highly tunable, cell-specific delivery leveraging the body’s intracellular communication channels equates to exceptional biocompatibility and low immunogenicity, offering promise for a range of precision medicine applications.

Harnessing the power of exosomes

Neucore is pioneering a proprietary platform of engineered fibroblast-derived extracellular vesicles to deliver therapeutic impact across areas of high unmet needs.

The unique regenerative biology of fibroblasts—cells central to tissue repair and structural integrity — enables restoration of function at the molecular level, offering a cost effective, scalable solution with curative potential.

Meet the Neucore Team

Kenneth L. Morand, Ph.D.

Kenneth L. Morand, Ph.D.

Co-founder and
Chief Executive Officer

Brian Price, Ph.D.

Brian Price, Ph.D.

Co-founder /
Chief Scientific Officer /
Chief Technology Officer

Silvia Duarte-Sanmiguel, PhD

Silvia Duarte-Sanmiguel, Ph.D.

R&D Director


Peter Kleinhenz

Peter Kleinhenz

Co-founder /
Board chair

Michael Triplett, Ph.D.

Michael Triplett, Ph.D.

Co-founder /
Board member

Daniel Gallego-Perez, Ph.D.

Daniel Gallego-Perez, Ph.D.

Scientific Co-founder
The Ohio State University

Natalia Higuita-Castro, Ph.D.

Natalia Higuita-Castro, Ph.D.

Scientific Co-founder
The Ohio State University

Contact us

Neucore Bio, Inc.
2281 Kenny Rd,
Columbus Ohio 43210
info@neucorebio.com

This field is for validation purposes and should be left unchanged.
Name(Required)